Diffuse large B cell lymphoma historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Diffuse large B cell lymphoma}} | {{Diffuse large B cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AEL}} | |||
==Overview== | |||
==Historical perspective== | |||
In 1865, Samuel Wilks used the term "Hodgkin's disease" in Annals of medicine on the name of "Thomas Hodgkin" who published a paper on some morbid appearances of absorbent glands and spleen in 1832<ref>Wilks S. Cases with enlargement of the lymphatic glands and spleen (or Hodgkin’s disease) with remarks. Guy’s Hosp Rep. 1865;11:57–67</ref><ref>{{Cite journal | In 1865, Samuel Wilks used the term "Hodgkin's disease" in Annals of medicine on the name of "Thomas Hodgkin" who published a paper on some morbid appearances of absorbent glands and spleen in 1832<ref>Wilks S. Cases with enlargement of the lymphatic glands and spleen (or Hodgkin’s disease) with remarks. Guy’s Hosp Rep. 1865;11:57–67</ref><ref>{{Cite journal | ||
| author = [[Ritu Lakhtakia]] & [[Ikram Burney]] | | author = [[Ritu Lakhtakia]] & [[Ikram Burney]] | ||
| Line 12: | Line 15: | ||
| month = May | | month = May | ||
| pmid = 26052452 | | pmid = 26052452 | ||
}}</ref><ref>{{Cite journal | |||
| author = [[Ahmedin Jemal]], [[Freddie Bray]], [[Melissa M. Center]], [[Jacques Ferlay]], [[Elizabeth Ward]] & [[David Forman]] | |||
| title = Global cancer statistics | |||
| journal = [[CA: a cancer journal for clinicians]] | |||
| volume = 61 | |||
| issue = 2 | |||
| pages = 69–90 | |||
| year = 2011 | |||
| month = March-April | |||
| doi = 10.3322/caac.20107 | |||
| pmid = 21296855 | |||
}}</ref>. Consequently, the other heterogeneous lymph node neoplastic disorder was later named as Non-Hodgkin's Lymphoma (NHL). Non-Hodgkin lymphoma is now one of the leading malignancies worldwide and Diffuse Large b cell Lymphoma (DLBCL) is one of the most common types of Non-Hodgkin Lymphoma | }}</ref>. Consequently, the other heterogeneous lymph node neoplastic disorder was later named as Non-Hodgkin's Lymphoma (NHL). Non-Hodgkin lymphoma is now one of the leading malignancies worldwide and Diffuse Large b cell Lymphoma (DLBCL) is one of the most common types of Non-Hodgkin Lymphoma | ||
Latest revision as of 16:48, 16 January 2019
|
Diffuse large B cell lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diffuse large B cell lymphoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Diffuse large B cell lymphoma historical perspective |
|
Diffuse large B cell lymphoma historical perspective in the news |
|
Blogs on Diffuse large B cell lymphoma historical perspective |
|
Directions to Hospitals Treating Diffuse large B cell lymphoma |
|
Risk calculators and risk factors for Diffuse large B cell lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Historical perspective
In 1865, Samuel Wilks used the term "Hodgkin's disease" in Annals of medicine on the name of "Thomas Hodgkin" who published a paper on some morbid appearances of absorbent glands and spleen in 1832[1][2][3]. Consequently, the other heterogeneous lymph node neoplastic disorder was later named as Non-Hodgkin's Lymphoma (NHL). Non-Hodgkin lymphoma is now one of the leading malignancies worldwide and Diffuse Large b cell Lymphoma (DLBCL) is one of the most common types of Non-Hodgkin Lymphoma
References
- ↑ Wilks S. Cases with enlargement of the lymphatic glands and spleen (or Hodgkin’s disease) with remarks. Guy’s Hosp Rep. 1865;11:57–67
- ↑ Ritu Lakhtakia & Ikram Burney (2015). "A Historical Tale of Two Lymphomas: Part I: Hodgkin lymphoma". Sultan Qaboos University medical journal. 15 (2): e202–e206. PMID 26052452. Unknown parameter
|month=ignored (help) - ↑ Ahmedin Jemal, Freddie Bray, Melissa M. Center, Jacques Ferlay, Elizabeth Ward & David Forman (2011). "Global cancer statistics". CA: a cancer journal for clinicians. 61 (2): 69–90. doi:10.3322/caac.20107. PMID 21296855. Unknown parameter
|month=ignored (help)